Extracellular vesicles (EVs), including exosomes and microvesicles, are 30-800 nm vesicles that are released by most cell types, as biological packages for intercellular communication. Their importance in cancer and inflammation makes EVs and their cargo promising biomarkers of disease and cell-free ...
Read More »UCLA Dentistry receives a $2.5 million grant from the National Cancer Institute to clinically validate liquid biopsy test
Researchers will partner with the UCLA Department of Pathology to make detection of non-small cell lung cancer more accurate and easier to detect with a saliva sample Lung cancer is a leading cause of cancer death among men and women. ...
Read More »Liquid Biopsy at Cancer Progression: This Is the Future
from Medscape by Liam Davenport – MUNICH — So-called liquid biopsies, which are based on standard blood draws, can identify molecular alterations that drive disease progression and hence drug resistance in almost 80% of patients, say researchers, who predict their ...
Read More »Efficient production and enhanced tumor delivery of engineered extracellular vesicles
Extracellular vesicles (EV), including exosomes and microvesicles, are nano-sized intercellular communication vehicles that participate in a multitude of physiological processes. Due to their biological properties, they are also promising candidates for the systemic delivery of therapeutic compounds, such as cytokines, ...
Read More »Seeking Cancer Clues in Blood, Researchers Explore Exosomes
A growing number of researchers and some biotech companies are exploring ways to use tiny vesicles called exosomes, which are released into the blood by cells, to gain insights into cancer and to develop clinical tools for patients. Recent studies ...
Read More »